does semaglutide affect potassium levels What's the soonest we can recheck the patient's level after the second dose of oral potassium replacement (20meq) to see if her hypokalemia has normalized? Managing hyperkalemia in the outpatient

Mutations of the BRAF gene in benign and malignant melanocytic lesions

Avoid shaking

Stroke 17 , 11561162 (2022)

The goal is finding your optimal therapeutic dose, not reaching the maximum dose available

Trial Metric Retatrutide 12mg (TRIUMPH-4) Semaglutide 2.4mg (STEP 1) Mean Weight Loss 28.7% at 68 weeks 14.9% at 68 weeks Mechanism Triple agonist (GLP-1/GIP/GCGR) Single agonist (GLP-1) FDA Status Phase 3 (investigational) Approved (Wegovy) Dosing Weekly subcutaneous Weekly subcutaneous Common Adverse Events GI (nausea, vomiting, diarrhea), dysesthesia GI (nausea, vomiting, diarrhea) Important caveat: These results come from different trial populations and study designs

Omada Health Evidence-backed GLP-1 Care for Ongoing Success Omadas proven behavior change program has led to sustainable outcomes during and after GLP-1 use